General Information of Drug (ID: DMU7YEL)

Drug Name
Sufentanil Drug Info
Synonyms
Chronogesic; Sufentanilum; Sufentanyl; Sulfentanil; Sulfentanyl; R 30730; R-30730; Sufenta (TN); Sufentanilum [INN-Latin]; Sufentil (TN); Sufentanil (USAN/INN); Sufentanil [USAN:BAN:INN]; N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidyl)propionanilide; N-[4-(methoxymethyl)-1-(2-thiophen-2-ylethyl)piperidin-4-yl]-N-phenylpropanamide; N-{4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide; N-{4-[(methyloxy)methyl]-1-[2-(2-thienyl)ethyl]piperidin-4-yl}-N-phenylpropanamide; N-(4-(Methoxymethyl)-1-(2-(2-thienyl)ethyl)-4-piperidinyl)-N-phenylpropanamide
Therapeutic ClassAnesthetics
Cross-matching ID
PubChem CID
41693
ChEBI ID
CHEMBL658
CAS Number
CAS 56030-54-7
TTD Drug ID
D0D8DD
VARIDT Drug ID
DR00602
INTEDE Drug ID
DR1508

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Citrate cycle (TCA cycle) 2.08 0.00e+0 30/30 (100%) SUCLG2;DLD;IDH1;...
Phosphatidylinositol signaling system 1.89 2.48e-2 82/97 (84.54%) PLCE1;ITPR1;DGKD;...
Fatty acid elongation 1.87 1.66e-2 19/27 (70.37%) HACD2;ELOVL5;ECHS1;...
Mismatch repair 1.85 1.55e-2 22/23 (95.65%) POLD4;MSH2;RFC2;...
Cholesterol metabolism -1.84 4.44e-2 44/50 (88%) APOH;APOE;ABCB11;...
Coronavirus disease -1.89 3.33e-2 215/232 (92.67%) RPS6;RPL41;RPSA;...
Ribosome -2.54 0.00e+0 113/158 (71.52%) RPS23;RPS27;RPS7;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.01uM - 10uM 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 24H